Really, really intriguing piece at Nature News by Heidi Ledford. It's all about a class of patients called "exceptional responders" — aka, the people who got a benefit (sometimes a big one) from a medication or treatment that otherwise failed the clinical trial process. When we do clinical trials, we're looking at group averages. We want to know whether a drug performed better than placebo when administered to lots of people. Sometimes, though, drugs that can't do that do seem to have a positive effect for a few lucky individuals. Now, scientists are trying to figure out why that is. What makes those people special? And how should this change the way we do research?
We're having a very special holiday sale on the Voyager Golden Record 3xLP box set that me and my buddies Timothy Daly and Lawrence Azerrad produced. It's now just $88… READ THE REST
Dozens of meters below the equator of Mars, researchers have discovered a pattern of honeycomb-shaped fractures like the one seen above. Captured with radar instruments on China's Zhurong robotic rover,… READ THE REST
US Berkeley researchers used artificial intelligence to determine that some of the clicks used by whales to communicate are "on many levels analogous to human vowels and dipthongs," the sound… READ THE REST
TL:DR; This super-soft Lavisha cashmere blend shawl is currently discounted to the affordable price of $16, a mere fraction of its original price, making it a great last-minute gift option. And since it'll… READ THE REST
TL;DR: If you're out of unique gift ideas, we may have a last-minute solution for the tech lover in your life. The Digi Pen for iPad and Tablets makes a great stocking stuffer,… READ THE REST
TL;DR: If you have a golf fan in your life, we know exactly what you need to get them this holiday season. The TruGolf Mini Golf Simulator will let them practice their… READ THE REST